National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

Recentin (reh-SEN-tin)

 A substance being studied in the treatment of some types of cancer. Recentin may prevent the growth of new blood vessels that tumors need to grow and may kill cancer cells. It is a type of antiangiogenesis agent and a type of vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor. Also called AZD2171 and cediranib.



Previous Definitions:RAV12, ravuconazole, RBC, rebeccamycin, rebeccamycin analog
Next Definitions:receptor, recombinant, recombinant adenovirus-p53, recombinant fowlpox-CEA-MUC-1-TRICOM vaccine, recombinant fowlpox-TRICOM vaccine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov